|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 771.00 EUR | -2.68% |
|
-1.46% | +28.50% |
| 12-04 | KBC Securities Upgrades Argenx to Buy, Boosts PT | MT |
| 12-02 | European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 54.89B | |||||
| 43.51B | - | ||||
| 38.12B | |||||
| 23.14B | - | ||||
| 19.5B | |||||
| 17.25B |
- Stock Market
- Equities
- ARGX Stock
- Charts argenx SE
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition